Howard Laura K, Meara Simon J P, Ibrahim Ehab M, Rowbottom Carl G
Medical Physics Department, Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
Department of Physics, University of Liverpool, Liverpool, UK.
J Appl Clin Med Phys. 2025 Jul;26(7):e70112. doi: 10.1002/acm2.70112. Epub 2025 Jun 5.
Sparing pharyngeal constrictor muscles (PCMs) during radiotherapy improves patient-reported swallowing function. This study aimed to explore the feasibility of integrating knowledge-based planning (KBP) with multicriteria optimization (MCO) in Eclipse v18.0 to selectively spare PCM, quantify the required trade-off in prophylactic planning target volume (PTV54) coverage, and to evaluate MCO performance.
Ten patients previously planned with KBP for oropharyngeal cancer (65, 60, and 54 Gy in 30 fractions) were retrospectively re-planned. Clinical plans were further optimized using trade-off exploration in MCO, with a priority order: spinal cord and brainstem sparing, high-dose and intermediate-dose target coverage, PCM sparing, low-dose target coverage, parotids sparing, remaining organs at risk (OAR). Plans were evaluated based on planning target volumes dose metrics (D, D, and D), homogeneity index (HI), conformity index (CI), and maximum and mean doses to OARs, and paired t-tests were performed. Differences between navigated and deliverable plans were analyzed. One patient underwent 10 identical repeat plan generations.
MCO reduced the average mean dose to the superior and middle PCM, inferior PCM, contralateral parotid, and larynx by 2.0, 3.4, 2.6, and 3.9 Gy, respectively (p < 0.05) but at the expense of HI and CI. No difference was observed in average PTV54 D between techniques; however, all clinical plans and seven MCO plans achieved D ≥ 95%, with three MCO plans modestly compromised (D 93.7%-94.6%). Dose metrics between navigated and deliverable plans differed by ≤0.7 Gy for mean doses and ≤1.8 Gy for maximum doses. Pareto surface generation was not repeatable.
MCO effectively balances the trade-off between PCM sparing and low-dose target coverage. It may be a valuable tool in the context of personalized care.
放疗期间保留咽缩肌(PCM)可改善患者报告的吞咽功能。本研究旨在探讨在Eclipse v18.0中将基于知识的计划(KBP)与多标准优化(MCO)相结合以选择性保留PCM的可行性,量化预防性计划靶体积(PTV54)覆盖所需的权衡,并评估MCO性能。
回顾性重新计划了10例先前采用KBP计划的口咽癌患者(30分次,剂量分别为65、60和54 Gy)。使用MCO中的权衡探索进一步优化临床计划,优先级顺序为:脊髓和脑干保留、高剂量和中剂量靶区覆盖、PCM保留、低剂量靶区覆盖、腮腺保留、其余危及器官(OAR)。根据计划靶体积剂量指标(D、D和D)、均匀性指数(HI)、适形指数(CI)以及OAR的最大和平均剂量对计划进行评估,并进行配对t检验。分析导航计划和可交付计划之间的差异。一名患者进行了10次相同的重复计划生成。
MCO分别将上、中PCM、下PCM、对侧腮腺和喉部的平均剂量降低了2.0、3.4、2.6和3.9 Gy(p < 0.05),但以HI和CI为代价。两种技术之间的平均PTV54 D未观察到差异;然而,所有临床计划和七个MCO计划的D≥95%,三个MCO计划略有妥协(D为93.7%-94.6%)。导航计划和可交付计划之间的剂量指标,平均剂量差异≤0.7 Gy,最大剂量差异≤1.8 Gy。帕累托表面生成不可重复。
MCO有效地平衡了PCM保留和低剂量靶区覆盖之间的权衡。在个性化医疗背景下,它可能是一个有价值的工具。